GB2023594A — 1-substituted alkyl-4-(3- trifluoromethylthiophenyl)- piperazines
Assigned to Synthelabo SA · Expires 1980-01-03 · 46y expired
What this patent protects
Compounds having the general formula (I> <IMAGE> in which n is 1, 2 or 3 and R represents (i) a group of formula: <IMAGE> (A) in which R1 and R2 represent hydrogen atoms or together represent a group of formula: <IMAGE> thereby completing a benzene ring …
USPTO Abstract
Compounds having the general formula (I> <IMAGE> in which n is 1, 2 or 3 and R represents (i) a group of formula: <IMAGE> (A) in which R1 and R2 represent hydrogen atoms or together represent a group of formula: <IMAGE> thereby completing a benzene ring fused to the heterocyclic ring shown in formula (A), X is a -S-, -O-, imino, alkyl-imino or methylene group and m is 0 or 1 or R represents (ii) a group of formula: <IMAGE> (B), (iii) a 2-tetrahydrofuryl group, (iv) a group of formula -CH2-S-Z, Z representing a hydrogen atom, alkyl group or -CO- alkyl group or (v) a group of formula -CH2-O- alkyl, having from 1 to 8 carbon atoms, and their pharmaceutically acceptable acid addition salts are useful in therapy, especially for treatment of anxiety and depression.
Drugs covered by this patent
- Addyi (FLIBANSERIN) · Sprout Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.